Leerink Partners analyst Mike Kratky maintained a Buy rating on Dexcom (DXCM – Research Report) on November 25 and set a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback